Exact skyrockets as Guardant blood test traces Cologuard in colon cancer
Guardian of health (GH) unveiled breakthrough results for its colon cancer blood test which lagged its rival Exact Sciences (EXAS) – leading GH stock to tumble on Friday. Meanwhile, the EXAS stock soared. X In the final phase study, Guardant Health said its blood test had an 83% sensitivity in detecting colon cancer. A highly …
Exact skyrockets as Guardant blood test traces Cologuard in colon cancer Read More »